Runx2 induces bone osteolysis by transcriptional suppression of TSSC1

•Overexpression of TSSC1 inhibits breast cancer metastasis.•Runx2 transcriptionally down-regulated TSSC1 expression.•Runx2 promotes breast cancer metastasis by down-regulation of TSSC1.•Runx2 mediates breast cancer-induced osteolytic bone disease in a TSSC-dependent manner. Advanced breast cancers f...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 438; no. 4; pp. 635 - 639
Main Authors Wang, Da-Chuan, Wang, Hai-Feng, Yuan, Ze-Nong
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 06.09.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•Overexpression of TSSC1 inhibits breast cancer metastasis.•Runx2 transcriptionally down-regulated TSSC1 expression.•Runx2 promotes breast cancer metastasis by down-regulation of TSSC1.•Runx2 mediates breast cancer-induced osteolytic bone disease in a TSSC-dependent manner. Advanced breast cancers frequently metastasize to bone, resulting in osteolytic lesions, however, the underlying mechanisms are poorly understood. Runx2, a bone-specific transcriptional factor, is abnormally expressed in highly metastatic breast cancer cells. Here, we found that TSSC1 inhibits breast cancer cell invasion. Subsequently, TSSC1 is confirmed as a target of Runx2 and is negatively regulated by Runx2. Furthermore, overexpression of Runx2 induces bone osteolysis in a TSSC1-dependent manner. Our results may provide a strategy for the treatment of breast cancer and the prevention of skeletal metastasis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2013.07.131